Leadership Move · Board · Healthcare
Rohit Malhotra joins Nirvaan Pharmaceuticals board as Independent Director
A former pharmaceutical CFO returns to the company he once reported for, this time chairing its audit committee.
The appointment
- Executive
- Rohit Malhotra
- New role
- Independent Director & Audit Committee Chair
- Company
- Nirvaan Pharmaceuticals
- Previous role
- Chief Financial Officer
- Previous company
- Nirvaan Pharmaceuticals
- Effective
- August 7, 2026
- Industry
- Healthcare
- Based
- Mumbai
Nirvaan Pharmaceuticals has appointed Rohit Malhotra as an independent director with effect from 7 August 2026. He will chair the audit committee. Malhotra was chief financial officer of the company between 2010 and 2019.
The re-appointment of a former executive as an independent director is permitted after a cooling-off period, and the company confirmed that the required interval had elapsed. Malhotra also sits on the board of Sentinel General Insurance.
He has said publicly that he will not take a fourth board seat, arguing that an independent director who cannot read a full board pack twice functions as a governance risk rather than a control. He has separately been critical of related-party disclosure standards in Indian mid-cap pharmaceuticals.
SourceNirvaan Pharmaceuticals board disclosure
Related moves
Arjun Bhatia promoted to Chief Operating Officer at Vaidya Health Networks
Healthcare · Delhi NCR
Rahul Menon appointed Chief Executive Officer of Arclight Systems
Technology · Bengaluru
Meridian Bank elevates Ananya Iyer to Chief Financial Officer
BFSI · Mumbai
ClubCXO Weekly
The leadership briefing for India’s business community.
The week’s most important CXO moves, leadership stories and executive insights — delivered every Monday.